4-n-butylresorcinol has been researched along with methyl-p-coumarate in 2 studies
| Studies (4-n-butylresorcinol) | Trials (4-n-butylresorcinol) | Recent Studies (post-2010) (4-n-butylresorcinol) | Studies (methyl-p-coumarate) | Trials (methyl-p-coumarate) | Recent Studies (post-2010) (methyl-p-coumarate) |
|---|---|---|---|---|---|
| 23 | 7 | 19 | 40 | 0 | 26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, SH; Manickam, M; Namasivayam, V; Pillaiyar, T | 1 |
| Haudecoeur, R; Pérès, B; Roulier, B | 1 |
2 review(s) available for 4-n-butylresorcinol and methyl-p-coumarate
| Article | Year |
|---|---|
Inhibitors of Melanogenesis: An Updated Review.
Topics: alpha-MSH; Biphenyl Compounds; Crystallization; Enzyme Inhibitors; Humans; Melanins; Monophenol Monooxygenase; Peptidomimetics; Radiation, Ionizing; Resveratrol; Signal Transduction; Skin | 2018 |
Advances in the Design of Genuine Human Tyrosinase Inhibitors for Targeting Melanogenesis and Related Pigmentations.
Topics: Agaricales; Amino Acid Sequence; Biological Factors; Drug Delivery Systems; Drug Design; Enzyme Inhibitors; Humans; Melanins; Melanocytes; Melanoma; Monophenol Monooxygenase; Pigmentation; Protein Structure, Secondary; Skin Lightening Preparations | 2020 |